Your browser doesn't support javascript.
loading
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.
Holland, Michael J; Beresford, Michael W; Feldman, Brian M; Huggins, Jennifer; Norambuena, Ximena; Silva, Clovis A; Susic, Gordana; Sztajnbok, Flavio; Uziel, Yosef; Appenzeller, Simone; Ardoin, Stacy P; Avcin, Tadej; Flores, Francisco; Goilav, Beatrice; Khubchandani, Raju; Klein-Gitelman, Marissa; Levy, Deborah; Ravelli, Angelo; Wenderfer, Scott E; Ying, Jun; Ruperto, Nicolino; Brunner, Hermine I.
Afiliação
  • Holland MJ; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Beresford MW; Alder Hey Children's National Health Service Foundation Trust and University of Liverpool, Liverpool, UK.
  • Feldman BM; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Huggins J; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Norambuena X; Hospital Dr. Exequiel Gonzalez Cortes, Santiago, Chile.
  • Silva CA; Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Susic G; Institute of Rheumatology, Belgrade, Serbia.
  • Sztajnbok F; Hospital Universitario Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Uziel Y; Meir Medical Centre, Kfar Saba, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Appenzeller S; University of Campinas Faculty of Medical Science, Campinas, Brazil.
  • Ardoin SP; Nationwide Children's Hospital, Ohio State University Wexner College of Medicine, Columbus.
  • Avcin T; Ljubljana University Medical Center, University of Ljubljana Medical Faculty, Ljubljana, Slovenia.
  • Flores F; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Goilav B; The Children's Hospital at Montefiore, Albert Einstein College of Medicine, New York, New York.
  • Khubchandani R; Jaslok Hospital and Research Center, Mumbai, India.
  • Klein-Gitelman M; Lurie Children's Hospital, Northwestern Feinberg School of Medicine, Chicago, Illinois.
  • Levy D; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Ravelli A; Istituto Giannina Gaslini and Università degli Studi di Genova, Genoa, Italy.
  • Wenderfer SE; Baylor College of Medicine and Texas Children's Hospital, Houston.
  • Ying J; University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Ruperto N; Istituto Giannina Gaslini and PRINTO, Genoa, Italy.
  • Brunner HI; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Arthritis Care Res (Hoboken) ; 70(11): 1621-1629, 2018 11.
Article em En | MEDLINE | ID: mdl-29409150
OBJECTIVE: To describe the frequency and types of disease damage occurring with childhood-onset systemic lupus erythematosus (SLE) as measured by the 41-item Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI), and to assess the SDI's ability to reflect damage severity. METHODS: Information for the SDI was prospectively collected from 1,048 childhood-onset SLE patients. For a subset of 559 patients, physician-rated damage severity measured by visual analog scale (MD VAS damage) was also available. Frequency of SDI items and the association between SDI summary scores and MD VAS damage were estimated. Finally, an international consensus conference, using nominal group technique, considered the SDI's capture of childhood-onset SLE-associated damage and its severity. RESULTS: After a mean disease duration of 3.8 years, 44.2% of patients (463 of 1,048) already had an SDI summary score >0 (maximum 14). The most common SDI items scored were proteinuria, scarring alopecia, and cognitive impairment. Although there was a moderately strong association between SDI summary scores and MD VAS damage (Spearman's r = 0.49, P < 0.0001) in patients with damage (SDI summary score >0), mixed-effects analysis showed that only 4 SDI items, each occurring in <2% of patients overall, were significantly associated with MD VAS damage. There was consensus among childhood-onset SLE experts that the SDI in its current form is inadequate for estimating the severity of childhood-onset SLE-associated damage. CONCLUSION: Disease damage as measured by the SDI is common in childhood-onset SLE, even with relatively short disease durations. Given the shortcomings of the SDI, there is a need to develop new tools to estimate the impact of childhood-onset SLE-associated damage.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2018 Tipo de documento: Article